This work, in collaboration with Pr. Rogier W. Sanders and Dr Marit van Gils of University Medical Centers in Amsterdam (Amsterdam UMC), demonstrated the efficacy of therapeutic NAbs rapidly developed for COVID-19 and its variants. https://angany.com/angany-canada-france-and-phylloceuticals-usa-two-biotechnology-innovators-team-up-to-accelerate-covid-nabs-commercialization/ https://phylloceuticals.com/